PubMed

Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.

Lindström T, Hedman CA, Arnqvist HJ.

Diabetes Care. 2002 Jun;25(6):1049-54.PMID: 12032113 [PubMed - indexed for MEDLINE]Related articlesFree article

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.

von Mach MA, Brinkmann C, Hansen T, Weilemann LS, Beyer J.

Exp Clin Endocrinol Diabetes. 2002 Nov;110(8):416-9.PMID: 12518253 [PubMed - indexed for MEDLINE]Related articles

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.

Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G.

Diabetes Care. 2003 Jul;26(7):2027-31.PMID: 12832307 [PubMed - indexed for MEDLINE]Related articlesFree article

A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.

Clin Ther. 2006 Oct;28(10):1649-57.PMID: 17157120 [PubMed - indexed for MEDLINE]Related articles

Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

Jacobs MA, Keulen ET, Kanc K, Casteleijn S, Scheffer P, Devillé W, Heine RJ.

Diabetes Care. 1997 Aug;20(8):1279-86.PMID: 9250454 [PubMed - indexed for MEDLINE]Related articles

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

Ahmed AB, Mallias J, Home PD.

Diabetes Care. 1998 Jul;21(7):1162-6.PMID: 9653613 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes.

Hedman CA, Orre-Pettersson AC, Lindström T, Arnqvist HJ.

Clin Endocrinol (Oxf). 2001 Jul;55(1):107-12.PMID: 11453959 [PubMed - indexed for MEDLINE]Related articles

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

Ahmed AB, Home PD.

Diabetes Care. 1998 Jan;21(1):32-7.PMID: 9538967 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

Lindholm A, McEwen J, Riis AP.

Diabetes Care. 1999 May;22(5):801-5.PMID: 10332685 [PubMed - indexed for MEDLINE]Related articlesFree article

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.

McSorley PT, Bell PM, Jacobsen LV, Kristensen A, Lindholm A.

Clin Ther. 2002 Apr;24(4):530-9.PMID: 12017398 [PubMed - indexed for MEDLINE]Related articles

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.

Hirao K, Maeda H, Urata S, Takisawa Y, Hirao S, Sasako T, Sasaki T.

Clin Ther. 2007 May;29(5):927-34.PMID: 17697911 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

Home PD, Lindholm A, Hylleberg B, Round P.

Diabetes Care. 1998 Nov;21(11):1904-9.PMID: 9802741 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.

Clin Ther. 2004 Sep;26(9):1492-7.PMID: 15531011 [PubMed - indexed for MEDLINE]Related articles

Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG.

Diabetes Care. 2007 Oct;30(10):2447-52. Epub 2007 Jul 10. Erratum in: Diabetes Care. 2008 Jan;31(1):188. PMID: 17623819 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

Diabetes Care. 2002 May;25(5):883-8.PMID: 11978685 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

Diabetes Care. 2003 May;26(5):1490-6.PMID: 12716810 [PubMed - indexed for MEDLINE]Related articlesFree article